Beskrivelse
Krav
IPC-klasse
Fullmektig i Norge:
Fullmektig i EP:
A J REPTA ET AL: "Utilization of an enantiomer as a solution to a pharmaceutical problem: Application to solubilization of 1,2-di(4-piperazine-2,6-dione)propane", JOURNAL OF PHARMACEUTICAL SCIENCES, vol. 65, no. 2, February 1976 (1976-02-01), pages 238 - 242, XP055130861, DOI: 10.1002/jps.260065021 (B1)
JONATHAN M. DANIELS ET AL: "DEVELOPMENT OF STEREOISOMERIC (CHIRAL) DRUGS: A BRIEF REVIEW OF SCIENTIFIC AND REGULATORY CONSIDERATIONS", DRUG INFORMATION JOURNAL (DRUGS.COM), vol. 31, 1997, US, pages 639 - 646, XP055254193, ISSN: 0092-8615, DOI: 10.1177/009286159703100303 (B1)
WO-A2-2006/048242 (B1)
PASCAL DE TULLIO ET AL: "Effective resolution of racemic pirlindole at the preparative scale", CHIRALITY, vol. 11, no. 4, 29 March 1999 (1999-03-29), pages 261 - 266, XP055131009, ISSN: 0899-0042, DOI: 10.1002/(SICI)1520-636X(1999)11:4<261::AID-CHIR1>3.3.CO;2-J (B1)
US-A- 5 053 407 (B1)
MICHEL F. EICHELBAUM, BERNARD TESTA, ANDREW SOMOGYI (EDITORS): "Stereochemical Aspects of Drug Action and Disposition (Handbook of Experimental Pharmacology)", part 5 10 April 2003, SPRINGER, ISBN: 3540415939, article C.-H. GU,D. J. W. GRANT: "Physical Properties and Crystal Structures of Chiral Drugs", pages: 113 - 139, XP009179283 (B1)
Statushistorie
Hovedstatus | Beslutningsdato, detaljstatus |
---|---|
EP patent gjort gjeldende i Norge | EP patent besluttet gjeldende i Norge |
EP under behandling | Forespørsel om å gjøre EP patent gyldig er mottatt |
Korrespondanse
Dato
Type korrespondanse
Journal beskrivelse
|
---|
Utgående
EP Varsel om betaling av første årsavgift (3319) (PTEP3831385)
|
Utgående
EP Registreringsbrev (3210) (PTEP3831385)
|
Innkommende
Søknadsskjema Patent
|
Innkommende
EP Publiseringsdokument fra EPO
|
Til betaling:
Betalingshistorikk:
Beskrivelse / Fakturanummer | Betalingsdato | Beløp | Betaler | Status |
---|---|---|---|---|
32411716 expand_more expand_less | 2024.09.16 | 7150 | Novagraaf Brevets | Betalt |
Valideringsgebyr EP-patent
7150 = 1 X 7150
|